Skip to main content
Signal8

Medicxi Ventures Management (Jersey) Ltd

SEC insider (Form 3/4/5 filer). CIK 0001715579. 10% Owner at Centessa Pharmaceuticals plc (CNTA) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in ST. HELIER.

Companies Medicxi Ventures Management (Jersey) Ltd has filed insider reports for

  • Centessa Pharmaceuticals plc (CNTA): 10% Owner
  • RAPT Therapeutics, Inc. (RAPT): 10% Owner
Medicxi Ventures Management (Jersey) Ltd profile photo

Medicxi Ventures Management (Jersey) Ltd

CIK: 0001715579

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Centessa Pharmaceuticals plc logo
CNTA

Centessa Pharmaceuticals plc

10% Owner
RAPT Therapeutics, Inc. logo
RAPT

RAPT Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Sale
    Indirect
    4.4M shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Sale
    Indirect
    55.7K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Sale
    Indirect
    3.9M shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Sale
    Indirect
    93.5K shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Sale
    Indirect
    11.2M shares-
  • Centessa Pharmaceuticals plc logo
    CNTA

    Centessa Pharmaceuticals plc

    Jun 24, 2026
    Sale
    Indirect
    281.2K shares-

1-6 of 6